Evidence map›Paper›PMID 29394295›Full record

ArticlePLoS pathogens2018

Pseudomonas aeruginosa rugose small-colony variants evade host clearance, are hyper-inflammatory, and persist in multiple host environments.

Matthew J Pestrak, Sarah B Chaney, Heather C Eggleston, Sheri Dellos-Nolan, Sriteja Dixit, Shomita S Mathew-Steiner, Sashwati Roy, Matthew R Parsek, Chandan K Sen, Daniel J Wozniak

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 75 papers.

0numbers the graph read from it
0cells of the map it votes in
75citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

75 citing papers in PubMed, 107 citations in OpenAlex.

  1. Journal of bacteriology · 2026
    Article
  2. Characterization of two exoUBMC microbiology · 2026
    Article
  3. Genetic diversification ofApplied and environmental microbiology · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Biofilm-associated molecular patterns: BAMPs.Infection and immunity · 2025
    Review
  8. bioRxiv : the preprint server for biology · 2025
    Article
  9. Review
  10. Article
  11. Article
  12. Urinary tract infections and catheter-associated urinary tract infections caused byMicrobiology and molecular biology reviews : MMBR · 2024
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

15 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Matthew J PestrakDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, United States of America.ORCID 0000-0002-7609-7537
Sarah B ChaneyDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, United States of America.
Heather C EgglestonDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, United States of America.ORCID 0000-0001-5217-4414
Sheri Dellos-NolanDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, United States of America.
Sriteja DixitDepartment of Surgery, The Ohio State University, Columbus, Ohio, United States of America.
Shomita S Mathew-SteinerDepartment of Surgery, The Ohio State University, Columbus, Ohio, United States of America.ORCID 0000-0002-7730-9140
Sashwati RoyDepartment of Surgery, The Ohio State University, Columbus, Ohio, United States of America.
Matthew R ParsekDepartment of Microbiology, University of Washington, Seattle, Washington, United States of America.
Chandan K SenDepartment of Surgery, The Ohio State University, Columbus, Ohio, United States of America.
Daniel J WozniakDepartment of Microbial Infection and Immunity, The Ohio State University, Columbus, Ohio, United States of America.
The Ohio State University · USUniversity of Washington · US

Funding

Translational Therapeutics Research Program (TT)P30CA016058 · NCI · OHIO STATE UNIVERSITY · PI Tasleem J Padamsee · 1985 to 2026
$132.3M
The pel exopolysaccharide gene cluster of Pseudomonas aeruginosaR01AI077628 · NIAID · UNIVERSITY OF WASHINGTON · PI MATTHEW R. PARSEK, Daniel J Wozniak · 2009 to 2026
$7.1M
Wound Healing Endpoint and RecurrenceR01NR015676 · NINR · OHIO STATE UNIVERSITY · PI GORDILLO, GAYLE M, ROY, SASHWATI · 2015 to 2019
$2.6M
Integrative Training in Biomedical SystemsT32GM068412 · NIGMS · OHIO STATE UNIVERSITY · PI PARVIN, JEFFREY D · 2005 to 2020
$2.4M
Biofilms and Immunity in Chronic WoundsR01NR013898 · NINR · OHIO STATE UNIVERSITY · PI SEN, CHANDAN K, WOZNIAK, DANIEL J · 2012 to 2016
$2.1M
Pseudomonas biofilms and immunityR01AI097511 · NIAID · OHIO STATE UNIVERSITY · PI WOZNIAK, DANIEL J · 2013 to 2017
$1.9M
Enzyme therapeutics for biofilm prevention and disruptionR33AI119116 · NIAID · HOSPITAL FOR SICK CHLDRN (TORONTO) · PI HOWELL, PATRICIA LYNNE · 2017 to 2019
$904k
Enzyme therapeutics for biofilm prevention and disruptionR21AI119116 · NIAID · HOSPITAL FOR SICK CHLDRN (TORONTO) · PI HOWELL, PATRICIA LYNNE · 2015 to 2016
$445k
NCI NIH HHS P30 CA016058NIAID NIH HHS R01 AI077628NIAID NIH HHS R01 AI097511NIAID NIH HHS R21 AI119116NIAID NIH HHS R33 AI119116NIGMS NIH HHS T32 GM068412NIH HHS AI097511NIH HHS AI119116NIH HHS NR013898NIH HHS NR015676NIH HHS P30 CA016058NINR NIH HHS R01 NR013898NINR NIH HHS R01 NR015676
6 · The paper itself

Abstract

Pseudomonas aeruginosa causes devastating infections in immunocompromised individuals. Once established, P. aeruginosa infections become incredibly difficult to treat due to the development of antibiotic tolerant, aggregated communities known as biofilms. A hyper-biofilm forming clinical variant of P. aeruginosa, known as a rugose small-colony variant (RSCV), is frequently isolated from chronic infections and is correlated with poor clinical outcome. The development of these mutants during infection suggests a selective advantage for this phenotype, but it remains unclear how this phenotype promotes persistence. While prior studies suggest RSCVs could survive by evading the host immune response, our study reveals infection with the RSCV, PAO1ΔwspF, stimulated an extensive inflammatory response that caused significant damage to the surrounding host tissue. In both a chronic wound model and acute pulmonary model of infection, we observed increased bacterial burden, host tissue damage, and a robust neutrophil response during RSCV infection. Given the essential role of neutrophils in P. aeruginosa-mediated disease, we investigated the impact of the RSCV phenotype on neutrophil function. The RSCV phenotype promoted phagocytic evasion and stimulated neutrophil reactive oxygen species (ROS) production. We also demonstrate that bacterial aggregation and TLR-mediated pro-inflammatory cytokine production contribute to the immune response to RSCVs. Additionally, RSCVs exhibited enhanced tolerance to neutrophil-produced antimicrobials including H2O2 and the antimicrobial peptide LL-37. Collectively, these data indicate RSCVs elicit a robust but ineffective neutrophil response that causes significant host tissue damage. This study provides new insight on RSCV persistence, and indicates this variant may have a critical role in the recurring tissue damage often associated with chronic infections.

Indexed as

Host-Pathogen InteractionsAnimalsBacterial AdhesionBacterial ProteinsCells, CulturedCytokinesFemaleGenetic VariationHumansMice, Inbred BALB CMicrobial ViabilityMicroscopy, ConfocalMutationNeutrophilsPhagocytosisPneumonia, BacterialBacterial ProteinsCytokinesReactive Oxygen Species

Identifiers

PMID29394295
PMCPMC5812653
OpenAlexW2786123473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.